Oculis
Clinical trials sponsored by Oculis, explained in plain language.
-
Eye drop trial aims to halt vision loss from diabetes
Disease control OngoingThis clinical trial is testing whether OCS-01 eye drops can safely improve vision and reduce swelling in the retina for people with diabetic macular edema (DME). The study involves 552 participants who will use either the active eye drops or a placebo (vehicle) for up to 52 weeks…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Eye drop trial offers new hope for diabetic vision loss
Disease control OngoingThis study is testing whether OCS 01 eye drops can safely improve vision in people with diabetic macular edema, a common cause of vision loss in diabetes. About 401 participants will use either the active eye drops or a placebo (vehicle) solution twice daily for a year. Researche…
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC